ArticleNeuro-oncology2026

Erratum to: Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma.

No numbers read from the abstract.

Not cited yet